1. HBW Insight
  2. >>Leadership

Cosmetics News: Ulta COO Adds Feather To Her Cap; Inter Parfums Q3; Perfect’s Hairstyling Virtual Try-On; More

 
• By Ryan Nelson

Battling organized retail crime, which Ulta has managed to curtail with new security fixtures in its stores, is just one of numerous areas overseen by Kecia Steelman, Ulta’s chief operating officer who added president to her title in September. More cosmetics news.

Kecia Steelman, Ulta’s chief operating officer who added president to her title in September, will continue overseeing work to combat organized retail theft, which impacted the company’s gross profit in the 2023 first fiscal quarter and continued to be a headwind in the second quarter, reported on 24 August. The retailer has installed new fixtures to combat the threat, placing fragrances and other high-priced items behind lock and key in more than 50% of its stores, with plans to have them installed in 70% of stores by year-end.

In an 18 October Institutional Equity Research report by D/A/Davidson, senior research analyst Michael Baker notes progress Ulta has made...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

Kris Joshi Named Norstella CEO, Prioritizes AI Innovation

 
• By Aakash Babu

Joshi joins the parent company of Citeline, home of HBW Insight, to focus on AI, business harmonization and long-term growth.

Over The Counter: How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.

Kennedy Appears Ill-Informed On Major Pharma Priorities, Creating Unique Lobbying Dynamics

 
• By Sarah Karlin-Smith

Health and Human Services secretary made incorrect statements about the status of key industry priorities at a recent House hearing, which actually may be a good thing for drug sponsors.

Biotech Investor, One-Time US FDA Commissioner Candidate Returns To HHS As RFK Jr.’s Top Deputy

 
• By Malcolm Spicer

Jim O’Neill recently was CEO of age-related diseases group SENS Research Foundation. After serving in HHS from 2002 to 2008, he became a managing director of Clarium Capital global investment fund and was Thiel Foundation CEO, funding nonprofits that promote technology.

More from HBW Insight

Kenvue Makes CEO Change Months After Critical Activist Investor Made Proxy Play For Board Seat

Thibaut Mongon is out as Kenvue CEO, a post he’s held since J&J spun it out in July 2023, after the firm’s results came under increased investor scrutiny over the past year. The board appointed as interim CEO Kirk Perry, a board member since December who most recently headed technology, data and pre

US House Passes ‘Do Not Flush’ Legislation For Non-Flushable Personal Care Wipes

 
• By Eileen Francis

The US House of Representatives passes legislation requiring manufacturers of non-flushable wet wipes to label products as ‘non-flushable," a move endorsed by the Personal Care Products Council.

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

 
• By Tom Gallen

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.